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Abstract
The antisaccade task, a hands- and language-free metric, may provide a functional
index of the dorsolateral prefrontal cortex (DLPFC), a region damaged in the later
stages of Alzheimer’s disease (AD). Our objective was to determine if patients with
mild AD made more errors relative to age-matched controls. Thirty patients with
mild AD (Mini Mental Status Exam [MMSE] ≥ 17) and 31 age-matched controls
completed a laptop version of the prosaccades and antisaccades tasks. Patients with
AD made more antisaccade errors, and corrected fewer errors, than age-matched
controls.Errorrates,correctedoruncorrected,werenotcorrelatedwithADMMSE
orDementiaRatingScalescores.Ourﬁndingsindicatethatantisaccadeimpairments
exist in mild AD, suggesting clinically detectable DLPFC pathology may be present
earlier than suggested by previous studies.
Introduction
The antisaccade task has been used increasingly to study
Alzheimer’sdisease(AD)becauseitprovidesaparsimonious
hands- and language-free measure of dorsolateral prefrontal
cortex (DLPFC) function (Kaufman et al. 2010). In the anti-
saccadetask,aneyemovementmustbedirectedintheoppo-
site direction from a sudden onset peripheral target (Hallett
1978).
Healthy individuals typically make antisaccade errors
(looking toward the target) on 20% of trials, while patients
with AD make between 50% and 80% errors (Crawford et al.
2005; Garbutt et al. 2008). Previous studies have included,
however,ADpatientsrangingfrommildtoseverelevelsofde-
mentia with mean Mini Mental Status Exam (MMSE) scores
between17and21(Currieetal.1991;Shaﬁq–Antonaccietal.
2003; Crawford et al. 2005; Garbutt et al. 2008). Reports of
a negative correlation between MMSE and antisaccade error
rates (low MMSE scores correspond with high error rates)
(Currieetal.1991;Shaﬁq–Antonaccietal.2003)suggestthat
the inclusion of more severely demented patients may have
exaggerated the differences in error rates between patients
and controls.
OurmainobjectivewastodeterminewhethermildADpa-
tients(MMSE≥17),makemoreerrorsthancontrolsandifso
whethererrorratescorrelatewithglobalcognitivemeasures.
Methods
Participants
Sixty-one participants, 30 Patients and 31 community-
dwelling age-matched normal volunteers were drawn from
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Table 1. Demographics1.
NC AD P
N 31 30
Sex (female) 18 11
Age 70.5 (8.2) (50–86) 72.3 (9.7) (51–92) ns
Years of
education
16 (2.6) (11–21) 14.9 (3.3) (10–21) ns
MMSE 29 (1.1) (26–30) 24.5 (3.2) (17–30) <0.01
DRS1 123.1 (10.3) (102–141)
1DRS scores only available on 19 patients in the AD group. Age, Years
of Education, MMSE, and DRS values are followed by standard deviation
and range.
theSunnybrookDementiaStudy,alargelongitudinalclinical
and multimodal imaging study of dementia (Table 1). Pa-
tients were diagnosed with probable Alzheimer’s Dementia
usingtheNINCDS-ADRDAcriteriaandtheDSM-IVcriteria
for dementia. Patients with neurological or psychiatric con-
d i t i o n so rM M S Es c o r e sl e s st h a n1 7w e r ee x c l u d e d .Ac u t o f f
score of <17 was chosen because 16 represent an inﬂection
point whereby the slope of cognitive decline increases signif-
icantly (Feldman et al. 2001). All patients and controls com-
pleted an MMSE; additionally the Mattis Dementia Rating
Scale (Mattis 1988) was obtained in 19 patients. All partici-
pants,ortheirdesignatedsubstitutedecisionmaker,provided
informed consent for the study, which was approved by the
Institutional Research Ethics Board. Although the propor-
tion of female and male participants was unequal between
the groups, it is unlikely this affected error rates, as there
is no published evidence for sex differences in antisaccade
performance (Ettinger et al. 2005).
Saccade tasks
The timing and stimulus of both the prosaccade task and
the antisaccade task were identical, the tasks only differed in
the instructions given to the participant prior to each block.
Eachparticipantﬁrstcompletedoneblockofprosaccadesand
then two blocks of antisaccades (24 pseudorandom trials per
block) (Fig. 1). The step paradigm, in which the central ﬁx-
ation point disappears in synchrony with the peripheral tar-
get’s appearance, was chosen because (1) it represents a tem-
poral compromise between the gap and overlap paradigms,
and (2) because fewer errors are typically made during the
stepparadigm,relativetothegapparadigm,itwaspresumed
thatelderlycontrolsandADpatientswouldbelessfrustrated
andmorecompliant.Althoughthedistancebetweenthecen-
ter and the peripheral target was held constant during each
trial,participantswereabletomovetheirheadfreely;thusthe
visualangleoftheoffsetwasnotequalforeachparticipant.To
demonstrate an understanding of the antisaccade task, prior
to the ﬁrst block, participants ﬁrst had to successfully point
to the location where they were supposed to look for three
consecutive trials (Connolly et al. 2000). Instructions were
repeated in between blocks. A laptop-integrated web camera
recorded the participants’ actions at 30 frames/sec.
Saccade coding
See Figure 2 for experimental setup. If the participant ﬁxated
centrally for at least two video frames, then made a saccade
in the correct direction two frames, after the experimenter
raised a ﬁnger and prior to the next trial, the response was
coded as correct. It is important to note that the frame rate
was variable (20–30 frames per second) for each video and
was chosen dynamically by the web camera software; thus,
two video frames for one video would be of slightly differ-
ent temporal length than two frames of another video. Two
frames were chosen to (1) ensure that participants followed
instructions and returned their gaze to center after each trial
and (2) determine that their eyes were not in motion. If they
failed to ﬁxate centrally before the next trial, their response
was coded as a ﬁxation error. Errors that were corrected be-
fore the next trial were coded as corrected errors, while those
left uncorrected were coded as uncorrected. Trials in which
no action was made were coded as omissions. Fixation and
omission errors were excluded from the analysis of antisac-
cadeerrorsandwereanalyzedseparately.Percentageoferrors
was deﬁned as: (corrected + uncorrected errors)/(no. of tri-
als) × 100. The correlation between results obtained by the
mainrater(LDK)andasecondrater(CA),whocodedvideos
from 20 participants (10 AD and 10 controls), was 0.88 (P <
0.001) indicating a high reliability for coding criteria.
Statistical analysis
All statistical analysis was completed with SPSS v 16.0 (SPSS,
Chicago, IL). Group comparisons were completed on each
of the demographic variables and saccade variables using
one-way analysis of variance (ANOVA). When the ANOVA
assumption of equal variances was not met (e.g., prosac-
cade errors, antisaccade: error rates, corrections, ﬁxations,
and omissions), the Welch’s robust tests of equality was uti-
lized(Welch1947).Toassessantisaccadeerrorratesinmilder
levels of AD, additional analysis was conducted on the sub-
group with MMSE scores >22 and another subgroup with
MMSE scores >24. The ﬁrst subgroup, with MMSE scores
>22 was selected to provide a direct comparison with the
study of Boxer and colleagues (Boxer et al. 2006), while the
second group (MMSE >24) was selected because an MMSE
score of 24 is usually considered a cutoff point for dementia.
Sensitivity, speciﬁcity, positive predictive value, and negative
p r e d i c t i v ev a l u ew e r ec a l c u l a t e dt oa s s e s st h ed i a g n o s t i cc a -
pacity of antisaccade errors, uncorrected errors, and ﬁxation
errors. Sensitivity and speciﬁcity calculation required binary
classiﬁcation of performance; therefore, antisaccade perfor-
mance was categorized as impaired (two standard deviations
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Figure 1. Laptop prosaccade and antisaccade
tasks. The ﬁxation star (75 pixels) disappeared
simultaneous to the appearance of a
peripheral target (75 pixels), 500 pixels left or
right of center. Stimulus was presented on a
Dell Inspiron 1520 Notebook with a 15.4
screen (1440 by 900 pixels) and participants
were recorded with the Notebook’s integrated
2.0 M pixel webcam.
above the normal controls [NC] mean) or unimpaired (un-
der two standard deviations of the NC mean). The effect
size of antisaccade error rates was calculated with Cohen’s d,
(the mean difference in antisaccade errors between the two
groups, divided by the pooled standard deviation) (Cohen
1998). Values derived from the Cohen’s d test are categorized
into effect sizes that are small (0.2–0.5), medium (0.5–0.8),
and large (≥0.8) (Cohen 1992).
Results
Demographic data for the 61 participants showed no sig-
niﬁcant baseline differences as summarized in Table 1. Per-
formance metrics are summarized in Table 2. Patients with
AD not only made signiﬁcantly more errors on both the
prosaccade (F(1,47.6)= 4.76, P < 0.05) and antisaccade tasks
(F(1,47.6)= 24.72, P < 0.001), but also left signiﬁcantly
more antisaccade errors uncorrected (F(1,29.5)= 22.3, P <
0.001). During the antisaccade task, patients made signiﬁ-
cantly more ﬁxation errors (F(1,31.7)= 23.6, P < 0.01) and
omission errors (F(1,31.4)= 8.1, P < 0.01) compared with
controls. Both subgroups with MMSE scores >22 (F(1,31.6)=
18.24, P < 0.001) and MMSE scores >24 (F(1,22.3)= 14.5,
P < 0.01) made signiﬁcantly more antisaccade errors
than NC.
Sensitivityandspeciﬁcity,andcutoffscoresareoutlinedin
Table 3. While all of the metrics provided speciﬁcities greater
than0.9,sensitivitywaslow,withuncorrectederrorsshowing
the highest sensitivity (sensitivity = 0.63). Prosaccade errors
werenotincludedinsensitivityandspeciﬁcityastheamount
of performance overlap between the two groups was large
(Cohen’s d = 0.56).
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Figure 2. Experimental setup. During the
laptop version, the experimenter stood behind
the participant and raised a right or left index
ﬁnger when the participant was suppose to
gaze right or left respectively, thus providing a
method by which observers of the web camera
videos could determine if the participant was
looking in the correct direction.
Table 2. Antisaccade performance.
NC (n = 31) AD (n = 30) AD > 22 (n = 22) AD > 24 (n = 17)
MMSE 29 (1.1) 24.5 (3.22)∗ 26.1 (2.0) 26.8 (1.6)
Errors 22 (18.4) 54.0 (30.3)∗∗ 53.5 (30.8)∗∗ 53.3 (31.1)∗
Uncorrected errors 1.2 (3.4) 32.4 (36.0)∗∗ 27.6 (33.4) 25.5 (31.0)
Fixation errors 1.8 (3.8) 17.4 (17.2)∗ 16.2 (16) 14.7 (14.5)
Omission errors 0.4 (1.1) 3.3 (5.5)∗ 3.2 (5.6) 4.0 (6.1)
Antisaccade errors are represented in percentages and are followed by their standard deviation. Group statistics were only carried out on values that
are followed by asterisks (∗P < 0.01; ∗∗P < 0.001), and are relative to the control group.
Table 3. Diagnostic capacity of antisaccade metrics.
Cutoff Number of impaired Sensitivity Speciﬁcity PPV NPV Cohen’s d
Errors >58.8% 15 AD, 1 NC 0.5 0.97 0.94 0.67 1.28
Uncorrected errors >7.9% 19 AD, 2 NC 0.63 0.94 0.9 0.73 1.22
Fixation errors >9.5% 16 AD, 2 NC 0.53 0.94 0.88 0.67 1.25
Omissions >2.7% 9 AD, 2 NC 0.3 0.94 0.82 0.58 0.73
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Figure 3. Antisaccade errors and Mini Mental
Status Exam (MMSE) scores are plotted on the
x-axis, while percentage of antisaccade errors
are plotted on the y-axis. Patients with
Alzheimer’s disease (AD) and normal controls
(NC) are represented by black diamonds and
gray circles, respectively.
Discussion
The current study examined antisaccade performance in
patients with mild AD and elderly controls using a novel
laptop-based antisaccade task. Patients with AD, even those
withMMSEcutoff>24,madesigniﬁcantlymoreantisaccade
errors than controls on both versions of the antisaccade task,
andleftsigniﬁcantlymoreerrorsuncorrected.Theeffectsizes
indicate a large mean magnitude of difference between the
two groups, which could be detected in smaller sample sizes.
However, despite these large effect sizes in antisaccade per-
formance, sensitivities were low because almost a third of
AD patients were unimpaired (Fig. 3). In contrast, antisac-
cade metrics are highly speciﬁc in this study sample, as only
two participants in the NC group were impaired. In contrast
to other studies (Currie et al. 1991; Shaﬁq–Antonacci et al.
2003;Boxeretal.2006),wedidnotﬁndacorrelationbetween
general measures of dementia, such as the MMSE or DRS,
and antisaccade error rates.
Antisaccade Errors Elevated
in Mild AD
Wehypothesizedthatpreviouslyreporteddifferencesinerror
rates between patients with mild AD and elderly controls
were mainly due to the inclusion of more severely demented
patients who tend to make 100% errors on the task. To test
this hypothesis, we tested AD patients with MMSE scores
≥17 and repeated our analysis on subsets of patients with
MMSE scores >22 and greater than 24.
To our knowledge, only the study conducted by Boxer
andcolleagues(Cohen1992)hasexaminedantisaccadeerror
ratesinmildADandtheydidnotﬁndasigniﬁcantdifference
from elderly controls. They posited that frontal pathology is
a late feature in AD and, thus, patients with mild AD would
not have “sufﬁcient” pathology to be impaired on the an-
tisaccade task (Boxer et al. 2006). Mild AD is thought to
correspond with Braak and Braak’s stage 4, a stage in which
neuroﬁbrillarychangesintheDLPFCarestillrelativelymild.
During Braak and Braak stages 5–6, which are thought to
correspond with moderate to severe AD, DLPFC pathology
is more evident (Braak and Braak 1991). It would thus be
expectedthatpersonswithmildADwouldhaveinsigniﬁcant
amounts of DLPFC pathology and would not be impaired
on the antisaccade task. However, using a larger sample size,
we have shown that about two-thirds of the patients with
mild AD do in fact make signiﬁcantly more errors than con-
trols, implicating sufﬁcient frontal neuropathology to reveal
aninvoluntarycontrolimpairment.Infact,thereismounting
evidencethatexecutivedeﬁcitsdooccurearlierindiseaseon-
set, during a pre-AD stage called mild cognitive impairment
and that in vivo amyloid pathology (Pike et al. 2007) and
DLPFC structural changes can be detected during MCI and
mild AD. For instance using MRI, Mosconi and colleagues
(Mosconietal.2007)identiﬁedasigniﬁcantdegreeofDLPFC
white matter atrophy in patients with MCI who progressed
to AD. Other reports suggest that AD is heterogeneous,
with a subset of AD demonstrating pronounced frontal
deﬁcits, causing diagnostic confusion with Frontotemporal
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Degeneration (FTD) (Snowden et al. 2007a), although the
self-regulatory disorder is less severe (Snowden et al. 2007b).
AlargeautopsysampleofclinicallydiagnosedFTDstudiedby
Snowden and colleagues contained only 2% of AD patients
with pronounced frontal deﬁcits, but it seems likely that a
continuum of DLPFC pathology may exist in AD with some
patients having intermediate degrees of frontal dysfunction.
As sample sizes become smaller, the probability of capturing
thevariationinfrontalpathologywoulddecrease.Hence,the
subset of patients studied by Boxer and colleagues (Boxer
et al. 2006) may have been less likely to capture this variation
than a study with a larger sample, such as the current study.
Dementia Severity and
Antisaccade Errors
A signiﬁcant correlation between general measures of de-
mentia, such as the DRS or the MMSE, has been consistently
reported, suggesting that error rates, and ultimately DLPFC
pathology, might simply be predicted by general levels of de-
mentia. We found that the mean antisaccade error rate of
AD patients, 55%, was relatively low compared with previ-
ously reported antisaccade error rates of 50–80%. Although
this study was not strictly comparable to previous studies,
the comparison reveals that the exclusion of more severely
demented patients may have resulted in lower mean error
rates relative to previous studies, which did include severely
demented patients.
We were unable to replicate the previously reported corre-
lations between error rates and MMSE scores within the AD
group, likely for several possible reasons. First, the relation-
ship between MMSE and antisaccade error rates in previous
studies may have been driven by the more severely demented
patients who consistently perform poorly on the antisaccade
task,andwereexcludedforourstudy.Asdiscussedabove,this
suggests that antisaccade error rates, and potentially frontal
neuropathology, may not reﬂect overall dementia severity
during mild stages of AD. Second, the heterogeneous nature
of AD renders the MMSE an unreliable metric for demen-
tia severity. For instance, lower MMSE scores might reﬂect
domain-speciﬁcimpairmentsinlanguageormemory,which
are heavily weighted in the MMSE, while executive functions
remained preserved, or at least are not well captured by the
MMSE. The DRS is more weighted for dorsolateral frontal
functions but the smaller sample size may have been insufﬁ-
cienttodetectcorrelation.Bothpossibilitiesarenotmutually
exclusiveandcouldcontributetothedifferencesbetweenthis
study’s ﬁndings and previous investigations.
We considered the possibility that the group differences
wereattributabletofailuretomaintaintaskinstructionsover
task blocks (Welch 1947). As noted in the methods, sub-
jects were required to point to the correct location where
they were supposed to look for three consecutive trials prior
to the start of the ﬁrst block. Instructions were reinforced
between blocks. Although loss of task set cannot be ruled
out as contributing to our ﬁndings, we do not consider this
to be explanatory as the patients appeared able to maintain
task set for the 72-sec duration of the block, as indicated
by their ability to switch instructional set between pro- and
antisaccade blocks, even though they were error prone. The
low rates of prosaccade errors (3.5% for AD versus 1.9% for
NC), although signiﬁcantly different, also suggests that the
AD patients were able to follow the instructions. To conclu-
sively rule out task set maintenance problems, future studies
shouldverifytasksetinstructionsbeforeandaftereachblock.
Augmenting ﬁxation cues with task set information, further
reducing the set maintenance element of the task, could be
used as a manipulation check to evaluate set maintenance
effects.
Conclusions
A progressive deﬁcit in episodic memory is the most promi-
nentfeatureofAD;however,thereisanincreasingawareness
that AD is heterogeneous and even early in the course can be
associated with varying degrees of impairment in the visu-
ospatial, executive, and language domains (Buck et al. 1997;
Galton et al. 2000; Alladi et al. 2007). Our ﬁndings highlight
that impairments in an inhibitory control function, man-
ifested by increased antisaccade errors, occur earlier in AD
thanpositedbypreviousantisaccadestudies,andthatinmild
AD antisaccade errors are not correlated with general mea-
sures ofdementiasuchas the MMSE.The ﬁndings presented
in this study provide further evidence that antisaccade er-
ror rates can be easily measured and may potentially provide
a clinical method for detecting early frontal dysfunction in
AD.
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